Chagas cardiomyopathy (CCM), first described in 1909 by Carlos Chagas, is still associated with high morbidity and mortality and socioeconomic impact, especially in Latin American countries. The search for epidemiological, clinical, laboratory, electrocardiographic, and image markers associated with its prognosis plays an important role in the risk stratification of these patients. […]
The World Health Organization (WHO) declared, on January 30, 2020, that the outbreak of the new coronavirus disease (COVID-19) constituted a Public Health Emergency of International Importance — the organization’s highest alert level as per its International Health Regulations. On March 11, 2020, COVID-19 was declared a pandemic. The fact that the lethality of COVID-19 is associated with common comorbidities has caused great concern among professionals who work with people with Down Syndrome (DS). The prevalence of cardiovascular diseases in […]
Clinical data The patient has developed no symptoms since birth, when heart disease was diagnosed by the presence of heart murmur in the presence of physical elements of Down syndrome. The patient is currently able to walk approximately 30 minutes daily without showing signs of fatigue and accompanies other individuals normally. The patient uses enalapril and levothyroxine for hypothyroidism. Physical examination: good overall status, eupneic, acyanotic, normal pulses in the 4 limbs. Weight: 41 kg, Height: 131 cm, MBP in […]
